Treatment of collagen diseases with cytostatics.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D003095:Collagen Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011111:Polymyalgia Rheumatica / Q000188:drug therapy; D013966:Thyroiditis / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D015122:Mercaptopurine; D001379:Azathioprine